MSA - Multiple System Atrophy Clinical Trial
Official title:
A Phase 3, Multi-center, Randomized Withdrawal and Long Term Extension Study of Ampreloxetine for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Participants With Multiple System Atrophy
This is a Phase 3, multi-center, randomized withdrawal study to evaluate the efficacy and durability of ampreloxetine in participants with MSA and symptomatic nOH after 20 weeks of treatment. This study includes 4 periods: Screening, open label, randomized withdrawal, and long-term treatment extension (LTE).
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02194816 -
Modifiable Variables in Parkinsonism (MVP)
|
||
| Recruiting |
NCT05698017 -
Study to Evaluate Investigational Allogeneic Cell Therapy Product hOMSC300 for Treatment of Early- to Moderate Stage MSA
|
Phase 1/Phase 2 | |
| Enrolling by invitation |
NCT04680130 -
Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders
|
||
| Recruiting |
NCT05486806 -
Longitudinal Tracking of Patients Diagnosed With Neurodegenerative Movement Disorders
|
||
| Completed |
NCT03577483 -
Differential Diagnosis Between Parkinson's Disease and Multiple System Atrophy Using Digital Speech Analysis
|
N/A | |
| Recruiting |
NCT02795052 -
Neurologic Stem Cell Treatment Study
|
N/A | |
| Recruiting |
NCT05197816 -
MotIoN aDaptive Deep Brain Stimulation for MSA
|
N/A | |
| Not yet recruiting |
NCT06120049 -
[18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DBL vs. AD
|
Phase 2/Phase 3 | |
| Completed |
NCT05011773 -
Manipulating and Optimising Brain Rhythms for Enhancement of Sleep
|
N/A | |
| Recruiting |
NCT05792332 -
Integrated Management of Atypical Parkinsonism: A Home-based Patient-Centered Healthcare Delivery Based on Telenursing (IMPACT Study)
|
N/A |